Corindus Vascular Robotics Adds to Management Team

Corindus Vascular Robotics Inc. has added two experienced leaders in the medical device industry to its management team.

Doug Teany was named senior vice president of research and development (R&D) and operations, effective March 21. Teany has an 18-year track record of driving operational excellence in the medical device and pharmaceutical industries. He joins Corindus from East River Consulting Group, where he specialized in scaling operations for emerging medical device companies.

Previously, Teany served as vice president in Boston Scientific Corp.’s R&D organization, responsible for strategy and operations of its global clinical and preclinical research functions. During his tenure at Boston Scientific, Teany played a key role in returning the company to profitability, contributing significantly to operating income growth through product development optimization and operational performance improvement. He designed and led numerous organizational transformations, improved operations for multiple large-scale laboratory and research facilities, and optimized the performance of pivotal development programs such as the Promus Element Stent and Lotus Valve TAVI systems.

Nora Dutta was named vice president of human resources, effective April 25. Dutta brings 19 years of human resources experience including organizational development, strategy, recruiting, and employee relations, joining Corindus from AMAG Pharmaceuticals, where she served as senior director of human resources. In that role, she provided strategic leadership on a transformational acquisition, was a member of the senior management team for its Hematology and Oncology Division and lead AMAG’s HR operations and recruitment functions.

Previously, Dutta served as a strategic HR business partner to the global strategy, marketing and business services functions at Boston Scientific. She was also a key team member on numerous acquisitions and strategic business initiatives during her eight-year tenure with Boston Scientific.

Teany and Dutta will be part of the Corindus senior leadership team, reporting directly to President and CEO Mark Toland.

“We are delighted to bring in two leaders with highly relevant experience and a long track record of successfully building high-performing teams and establishing organizational excellence,” said Toland. “We welcome Doug and Nora to our team, and look forward to their many contributions as we enter this next stage of growth.”

Corindus Vascular Robotics, Inc. is a developer of robotic-assisted vascular intervention technology. The Waltham, Mass.-based company’s CorPath System is the first U.S. Food and Drug Administration-cleared medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.